Peginterferon alfa-2b

Peginterferon alfa-2b is a man-made form of a protein that occurs naturally in the body. It is a type of interferon that is used to treat certain types of hepatitis C virus (HCV) infections. It is usually given in combination with other medications, such as ribavirin, to help reduce the amount of HCV in the body. Common side effects include flu-like symptoms, fatigue, headache, muscle and joint pain, and depression.

Peginterferon alfa-2b, similar to its close cousin Peginterferon alfa-2a, is a medication used to combat viral infections. Here's a breakdown of its key features:

Main Uses:

  • Chronic Hepatitis C: Peginterferon alfa-2b was previously a primary treatment for chronic hepatitis C, typically combined with ribavirin. However, due to the emergence of newer medications with better efficacy and fewer side effects, its use for this purpose has significantly declined.
  • Melanoma: In some countries, peginterferon alfa-2b is used as an adjuvant therapy (given after surgery) for high-risk melanoma, a type of skin cancer. The effectiveness of this use is debated due to the frequency of severe side effects and varying survival benefits across studies.

How it Works:

  • Peginterferon alfa-2b belongs to the class of interferons, which are natural proteins produced by the body's immune system to fight viruses. This medication mimics these natural interferons, stimulating the immune system to attack the hepatitis C virus or melanoma cells.
  • The "peginterferon" part indicates that the medication is a modified version. A molecule called polyethylene glycol (PEG) is attached, allowing it to stay active in the body for a longer duration compared to natural interferon.

Important Considerations:

  • Dosage and Administration: Peginterferon alfa-2b is administered as an injection under the skin (subcutaneously) usually once a week. The specific dosage and treatment length depend on the condition being treated and other individual factors.
  • Side Effects: Peginterferon alfa-2b can cause various side effects, some common and others more serious. Common side effects include fatigue, flu-like symptoms, headache, depression, muscle aches, nausea, and hair loss. Serious side effects may include severe depression, suicidal thoughts, autoimmune disorders, and blood clots.
  • Current Use in Hepatitis C: Due to the development of Direct-Acting Antivirals (DAAs) with higher cure rates and fewer side effects, peginterferon alfa-2b is rarely used for Hepatitis C treatment anymore. DAAs are now the preferred option.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L03 Immunostimulants
L03A - Immunostimulants
L03AB Interferons
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L03 Immunostimulants
L03A - Immunostimulants
L03AB Interferons
External Links